Research supports the development of systems that combine
advanced sensors with artificial intelligence to enhance insights
into health and well-being
Rockley Photonics (NYSE: RKLY), a global leader in
photonics-based health monitoring and communications solutions,
today announced a new research collaboration that will focus on the
development of next-generation solutions that combine advanced
sensors with artificial intelligence. The collaboration includes
Caltech’s Sensing to Intelligence (S2I) Center.
The S2I Center seeks to bring together two typically isolated
disciplines — the field of sensing and imaging and the field of
computation and algorithms — by adopting a holistic,
interdisciplinary approach. The goal of bringing these two fields
together is to develop more powerful and intelligent sensing
systems and is wholly aligned with Rockley’s approach to health and
wellness monitoring, which combines photonics-based sensor
technologies with state-of-the-art artificial intelligence (AI) and
data analytics.
Through its investment in S2I, Rockley plans to support a range
of projects, including the development of new integrated
spectrometer technologies using advanced photonics sensors.
Researchers in the S2I center will explore and further analyze the
relationship between spectral data and individual biomarkers to
broaden and enhance the health monitoring capabilities and will
utilize Rockley’s platform in the process.
Rockley Photonics and Caltech have collaborated previously on
research projects including co-packaged optics and the co-design
and integration of advanced photonics and electronics. This new
agreement deepens an already strong association.
“Over the years, we have had a wonderful relationship with our
Pasadena neighbors at Caltech, and it is an honor to continue our
research agreement with them through the S2I Center,” said Dr.
Andrew Rickman, chief executive officer and founder of Rockley
Photonics. “Caltech has a strong history of supporting the
development of health-related technologies, including Professor
Arnold Beckman’s invention of the DU spectrophotometer, which was
hailed as perhaps the most important instrument ever developed
toward the advancement of bioscience. This new partnership will
combine our experience building Rockley’s unique biomarker sensing
platform, which incorporates a spectrophotometer-on-a-chip, with
Caltech’s extensive research capabilities. We are happy to be
working with Caltech once again to push the boundaries of
bioscience even further.”
The scope of the partnership with S2I involves multiple Caltech
divisions and departments, including Electrical Engineering,
Applied Physics, Medical Engineering, Computing and Mathematical
sciences, and NASA’s Jet Propulsion Laboratory (JPL).
“With support from Rockley, we believe we have an opportunity to
leverage integrated sensor technologies and machine learning
algorithms to create intelligent sensor systems that process and
make sense of the data, help avoid information overload for
patients and doctors, and do a better job of avoiding false
positives,” said Azita Emami, Andrew and Peggy Cherng Professor of
Electrical Engineering and Medical Engineering at Caltech and
director of the S2I initiative. “We believe that the potential for
transforming personal healthcare and well-being is limitless.”
Leveraging Rockley’s and Caltech’s experience developing AI
solutions for biosensing and healthcare, the collaboration will
also explore new applications for cloud-based services, exploiting
the advanced capabilities of platforms such as Amazon Web Services
(AWS).
“We’re very excited to be expanding our partnership with Caltech
by supporting the S2I Center as an industry partner,” said Aaron
Zilkie, chief technology officer of photonics at Rockley Photonics.
“The cross-disciplinary research mandate of the S2I Center, which
brings together experts from multiple fields across photonics,
electronics, biology, and AI in both academia and industry, is
highly synergistic with Rockley’s goal of working with top research
talent to develop the most advanced smart health monitoring and
sensing solutions. Plus, with AWS's support of Caltech’s research
related to basic science and AI, we think this research partnership
is exactly the kind of collaboration that the field needs.”
About Rockley Photonics
A global leader in photonics-based health monitoring and
communications solutions, Rockley Photonics is developing a
comprehensive range of photonic integrated circuits and associated
modules, sensors, and full-stack solutions. From next-generation
sensing platforms specifically designed for mobile health
monitoring and machine vision to high-speed, high-volume solutions
for data communications, Rockley is laying the foundation for a new
generation of applications across multiple industries. Rockley
believes that photonics will eventually become as pervasive as
micro-electronics, and it has developed a platform with the power
and flexibility needed to address both mass markets and a wide
variety of vertical applications.
Formed in 2013, Rockley is uniquely positioned to support
hyper-scale manufacturing and address a multitude of high-volume
markets. Rockley has partnered with numerous Tier-1 customers
across a diverse range of industries to deliver the complex optical
systems required to bring transformational products to market.
To learn more about Rockley, visit rockleyphotonics.com.
Cautionary Note Regarding Forward-Looking Statements
Statements in this press release that are not historical facts
constitute “forward-looking statements” for purposes of the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. These forward-looking statements include statements
regarding Rockley’s future expectations, beliefs, plans,
objectives, and assumptions regarding future events or performance.
The words “accelerate,” “advance,” “anticipate,” “believe,” “can,”
“continue,” “could,” “develop,” “enable,” “estimate,” “eventual,”
“expand, “expect,” “focus,” “future,” “goal,” “intend,” “may,”
“might,” “opportunity,” “outlook,” “plan,” “possible,” “position,”
“potential,” “predict,” “project,” “revolutionize,” “seem,”
“should,” “trend,” “vision,” “will,” “would” or other terms that
predict or indicate future events, trends, or expectations, and
similar expressions or the negative of such expressions may
identify forward-looking statements, but the absence of these words
or terms does not mean that a statement is not forward-looking.
Forward-looking statements in this press release include, but are
not limited to, statements regarding the following: (a) the
anticipated focus, benefits, scope, and potential of Rockley’s
collaboration with Caltech, including with respect to Caltech’s S2I
Center, the goals and focus of these efforts and their alignment
with Rockley’s approach to health and wellness monitoring, the
expected range of projects to be supported by Rockley through its
investment in S21, the expected areas of research and analysis, the
potential to broaden and enhance the health monitoring capabilities
utilizing Rockley’s platform, the expectation that the partnership
will combine Rockley’s experience building Rockley’s unique
biomarker sensing platform with Caltech’s research capabilities,
the opportunity to leverage intelligent sensor technologies and
machine learning algorithms to create intelligent sensor systems
and the potential benefits thereof, the potential for transforming
personal healthcare and wellbeing, the exploration of potential new
applications for, and exploiting the capabilities of, cloud-based
services; (b) the anticipated and potential features and benefits
of Rockley’s platform, products, and technology; (c) its
development of a range of photonic integrated circuits and
associated modules, sensors, and full-stack solutions; (d)
Rockley’s belief that photonics will eventually become as pervasive
as micro-electronics; and (e) Rockley’s potential to support
hyper-scale manufacturing, address a multitude of high-volume
markets, and deliver the complex optical systems required to bring
transformational products to market.
Forward-looking statements are subject to several risks and
uncertainties (many of which are beyond Rockley’s control) or other
assumptions that may cause actual results or performance to differ
materially from those expressed or implied by these forward-looking
statements. These risks and uncertainties include, but are not
limited to, the following: (i) Rockley’s ability to achieve
customer acceptance and commercial production of its products and
technology, including in a timely and cost-effective manner; (ii)
Rockley’s ability to achieve customer design wins and convert
memoranda of understanding and development contracts into
production contracts; (iii) risks related to purchase orders,
including the lack of long-term purchase commitments, the
cancellation, reduction, delay, or other changes in customer
purchase orders, and if and to the extent customers seek to enter
into licensing arrangements in lieu of purchases; (iv) Rockley’s
history of losses and need for additional capital and its ability
to access additional financing to support its operations and
execute on its business plan, as well as the risks associated
therewith; (v) legal and regulatory risks; (vi) risks associated
with its fabless manufacturing model and dependency on third-party
suppliers; (vii) Rockley’s reliance on a few significant customers
for a majority of its revenue and its ability to expand and
diversify its customer base; (viii) Rockley’s financial
performance; (ix) the impacts of COVID-19 on Rockley, its customers
and suppliers, its target markets, and the global economy; (x)
Rockley’s ability to successfully manage growth and its operations
as a public company; (xi) fluctuations in Rockley’s stock price and
Rockley’s ability to maintain the listing of its ordinary shares on
the NYSE; (xii) Rockley’s ability to anticipate and respond to
industry trends and customer requirements; (xiii) changes in the
current and future markets in which Rockley is or may be engaged;
(xiv) risks related to competition and intellectual property; (xv)
market opportunity and demand for Rockley’s products and
technology, as well as the customer products into which Rockley’s
products and technology are incorporated; (xvi) risks related to
international operations; (xvii) risks related to cybersecurity,
privacy, and infrastructure; (xviii) risks related to financial and
accounting matters; (xix) general economic, financial, political,
and business conditions, both domestic and foreign; (xx) Rockley’s
ability to realize the anticipated benefits of its completed
business combination with SC Health Corporation; and (xxi)
Rockley’s ability to realize the anticipated benefits of strategic
partnerships, as well as other factors described under the heading
“Risk Factors” in registration statement on Form S-1 filed by
Rockley on October 7, 2021 and declared effective on October 19,
2021, Rockley’s quarterly report on Form 10-Q for the quarter ended
June 30, 2021, and in other documents Rockley files with the
Securities and Exchange Commission in the future.
The forward-looking statements contained in this press release
are based on various assumptions, whether or not identified in this
press release, and on Rockley’s current expectations, beliefs, and
assumptions and are not predictions of actual performance. If any
of these risks or uncertainties materialize, or should any of these
assumptions prove incorrect, actual results may differ materially
from those discussed in or implied by these forward-looking
statements. There can be no assurance that future developments
affecting Rockley will be those that have been anticipated. These
forward-looking statements speak only as of the date hereof and
Rockley does not intend to update or revise any forward-looking
statements, whether because of new information, future events, or
otherwise, except as required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211110005697/en/
Media Karen Boud Resonates Telephone: +44 1635 898 698 Email:
rockley@resonates.com
Investors Gwyn Lauber Rockley Photonics Telephone: +1
626-995-0001 Email: investors@rockleyphotonics.com
Rockley Photonics (NYSE:RKLY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Rockley Photonics (NYSE:RKLY)
Historical Stock Chart
From Apr 2023 to Apr 2024